Earnings History Data for XOMA Royalty Corporation (XOMA) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
XOMA Royalty Corporation
XOMA Corporation is a biopharmaceutical company engaged in the discovery, development, and manufacturing of therapeutic antibodies to treat autoimmune, infectious, inflammatory, and oncological diseases. The company's flagship product is gevokizumab, a humanized antibody to interleukin-1? with potential for the treatment of the inflammatory cause of multiple diseases. XOMA Corporation, formally known as XOMA Ltd., is headquartered in Berkeley, California.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07-11-2024 | PM | XOMA | XOMA Royalty Corporation | 363.00 | -0.39 | -0.44 | 0.00 | XOMA GAAP EPS of -$1.59, revenue of $7.2M [11/7/2024 9:14 AM] |
30.83 | -1.63 (-5.04%) |
31.12 | -1.34 (-4.13%) |
14.27 - 33.78 | 26,805 | 30,000 | 452 | ||
| 09-05-2024 | PM | XOMA | XOMA | 285.00 | -0.86 | -0.71 | 0.00 | XOMA GAAP EPS of -$0.86, revenue of $1.49M [5/9/2024 7:53 AM] |
23.77 | -0.43 (-1.76%) |
0.0 | 0.0 (0.00%) |
13.48 - 27.00 | 6,557 | 10,000 | 0 | ||
| 08-03-2024 | PM | XOMA | XOMA | 287.00 | -0.49 | -0.36 | 0.00 | XOMA GAAP EPS of -$4.04 misses by $1.99, revenue of $4.76M misses by $1.74M [3/8/2024 7:36 AM] |
25.02 | -0.10 (-0.40%) |
0.0 | 0.0 (0.00%) |
13.48 - 25.91 | 4,735 | 20,000 | 0 | ||
| 07-11-2023 | PM | XOMA | XOMA | 211.00 | -0.60 | -0.48 | 0.00 | XOMA GAAP EPS of -$0.60 misses by $0.12, revenue of $0.83M misses by $0.36M [11/7/2023 7:58 AM] |
16.34 | -1.04 (-5.98%) |
0.0 | 0.0 (0.00%) |
13.48 - 26.00 | 12,730 | 40,000 | 0 | ||
| 08-08-2023 | PM | XOMA | XOMA | 181.00 | -0.59 | -0.52 | 0.00 | XOMA GAAP EPS of -$0.59, revenue of $1.7M [8/8/2023 7:53 AM] |
15.82 | -0.12 (-0.72%) |
0.0 | 0.0 (0.00%) |
15.21 - 26.00 | 16,383 | 20,000 | 0 | ||
| 09-05-2023 | PM | XOMA | XOMA | 210.00 | -0.98 | -0.50 | 0.00 | XOMA GAAP EPS of -$0.98, revenue of $0.44M [5/9/2023 7:42 AM] |
18.32 | 0.06 (0.33%) |
0.0 | 0.0 (0.00%) |
15.68 - 32.08 | 22,625 | 30,000 | 0 | ||
| 08-03-2022 | PM | XOMA | XOMA | 237.00 | 1.67 | 2.68 | 0.00 | XOMA GAAP EPS of $1.67 misses by $0.60, revenue of $35.94M beats by $0.8M [3/8/2022 7:49 AM] |
23.02 | 1.49 (6.92%) |
0.0 | 0.0 (0.00%) |
19.08 - 41.99 | 8,115 | 30,000 | 0 | ||
| 06-05-2021 | PM | 7:30 AM ET (May 6) |
XOMA | Xoma Corporation | 399.00 | -0.70 | -0.15 | 0.00 | XOMA EPS misses by $0.55, misses on revenue [5/6/2021 7:57 AM] |
31.26 | -2.99 (-8.73%) |
33.06 | -1.19 (-3.48%) |
15.48 - 46.32 | 74,934 | 30,000 | 1,120 | |
| 10-03-2021 | PM | 7:30 AM ET (Mar 10) |
XOMA | XOMA Corporation | 407.27 | 1.32 | 1.29 | -0.49 | XOMA EPS misses by $0.68, beats on revenue [3/10/2021 7:54 AM] |
38.35 | 0.72 (1.91%) |
39.69 | 2.06 (5.47%) |
14.14 - 46.32 | 22,199 | 21,055 | 1,414 | |